ArticleTherapeutic innovation & regulatory science2026
BOP2-Comb: Bayesian Optimal Phase II Design for Optimizing Doses and Assessing Contribution of Components in Drug Combinations.
Xiaohan Chi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.